På väg mot evidensbaserad terapi vid primär systemisk vaskulit. De senaste decenniernas framsteg har gett dagens patienter bättre läge
(2007) In Läkartidningen 104(12). p.954-957- Abstract
- The prospects for patients suffering from systemic small vessel vasculitis have improved substantially in recent decades. The introduction of cyclophosphamide in the 1970s led to a dramatic improvement in survival rates. The discovery of ANCA meant a substantial increase in the number of detected cases, especially among elderly patients, as well as detection at an earlier stage of disease. At the beginning of the 1990s consensus was reached to change the classification of vasculitis, providing a framework for international multicentre studies. Now that results from such studies are available, at least some decisions regarding the care of vasculitis patients can be considered to be evidence-based.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1140505
- author
- Segelmark, Mårten LU and Westman, Kerstin LU
- organization
- publishing date
- 2007
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Läkartidningen
- volume
- 104
- issue
- 12
- pages
- 954 - 957
- publisher
- Swedish Medical Association
- external identifiers
-
- pmid:17469311
- scopus:33947510149
- ISSN
- 0023-7205
- language
- English
- LU publication?
- yes
- id
- 2eaf7b93-6eeb-4cdd-bf32-472fffce1880 (old id 1140505)
- alternative location
- http://ltarkiv.lakartidningen.se/artNo33174
- date added to LUP
- 2016-04-04 09:30:17
- date last changed
- 2022-01-29 18:10:58
@article{2eaf7b93-6eeb-4cdd-bf32-472fffce1880, abstract = {{The prospects for patients suffering from systemic small vessel vasculitis have improved substantially in recent decades. The introduction of cyclophosphamide in the 1970s led to a dramatic improvement in survival rates. The discovery of ANCA meant a substantial increase in the number of detected cases, especially among elderly patients, as well as detection at an earlier stage of disease. At the beginning of the 1990s consensus was reached to change the classification of vasculitis, providing a framework for international multicentre studies. Now that results from such studies are available, at least some decisions regarding the care of vasculitis patients can be considered to be evidence-based.}}, author = {{Segelmark, Mårten and Westman, Kerstin}}, issn = {{0023-7205}}, language = {{eng}}, number = {{12}}, pages = {{954--957}}, publisher = {{Swedish Medical Association}}, series = {{Läkartidningen}}, title = {{På väg mot evidensbaserad terapi vid primär systemisk vaskulit. De senaste decenniernas framsteg har gett dagens patienter bättre läge}}, url = {{http://ltarkiv.lakartidningen.se/artNo33174}}, volume = {{104}}, year = {{2007}}, }